Zobrazeno 1 - 10 of 31 pro vyhledávání: '"Ann-Charlotte Johansson"'
1
Akademický článek
A CD44high/EGFRlow subpopulation within head and neck cancer cell lines shows an epithelial-mesenchymal transition phenotype and resistance to treatment.
Autor: Linnea La Fleur, Ann-Charlotte Johansson, Karin Roberg
Publikováno v: PLoS ONE, Vol 7, Iss 9, p e44071 (2012)
Mortality in head and neck squamous cell carcinoma (HNSCC) is high due to emergence of therapy resistance which results in local and regional recurrences that may have their origin in resistant cancer stem cells (CSCs) or cells with an epithelial-mes
Externí odkaz: https://doaj.org/article/05c796357f2b420b91cfbd7a5706e265
Zobrazit plný text záznamu
2
Data from Cancer-Associated Fibroblasts Induce Matrix Metalloproteinase–Mediated Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cells
Autor: Karin Roberg, Arne Östman, Eva Munck-Wikland, Reidar Grénman, Maja Bradic Lindh, Fredrik Jerhammar, Anna Ansell, Ann-Charlotte Johansson
A growing body of evidence suggests that components of the tumor microenvironment, including cancer-associated fibroblasts (CAF), may modulate the treatment sensitivity of tumor cells. Here, we investigated the possible influence of CAFs on the sensi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aaa79859c9f4c5d9a2e5531b2b9fe70e
https://doi.org/10.1158/1541-7786.c.6541521
Zobrazit plný text záznamu
6
Cetuximab sensitivity of head and neck squamous cell carcinoma xenografts is associated with treatment-induced reduction in EGFR, pEGFR, and pSrc
Autor: Per-Henrik Edqvist, Karin Roberg, Ann-Charlotte Johansson, Fredrik Pontén, Stina Garvin, Adam Jedlinski
Publikováno v: Journal of Oral Pathology & Medicine. 46:717-724
The aims of this study were to validate in vitro drug sensitivity testing of head and neck squamous cell carcinoma (HNSCC) cell lines in an in vivo xenograft model and to identify treatment-induced changes in the epidermal growth factor receptor (EGF
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67cc2e9a8f7b934c72a23a7e7feb7a94
https://doi.org/10.1111/jop.12545
Zobrazit plný text záznamu
7
The relationship between EMT, CD44high /EGFRlow phenotype, and treatment response in head and neck cancer cell lines
Autor: Karin Roberg, Linnea La Fleur, Ann-Charlotte Johansson, Styliani Melissaridou
Publikováno v: Journal of Oral Pathology & Medicine. 45:640-646
Background Head and neck squamous cell carcinoma (HNSCC) tumors are often therapy resistant and may originate from cancer stem cells or tumor cells with an epithelial-to-mesenchymal transition (EMT) phenotype. The aim of this study was to characteriz
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cceda436187c2c7319ab11e0272a5e63
https://doi.org/10.1111/jop.12423
Zobrazit plný text záznamu
8
Epidermal growth factor is a potential biomarker for poor cetuximab response in tongue cancer cells
Autor: Adam Jedlinski, Karin Roberg, Anna Ansell, Ann-Charlotte Johansson
Publikováno v: Journal of Oral Pathology & Medicine. 45:9-16
Head and neck squamous cell carcinoma is frequently associated with aberrant epidermal growth factor receptor (EGFR) signaling, which contributes to tumor growth. Here, the functional importance of EGFR ligands in relation to proliferation and sensit
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f97cabda7f628f6f3ac8bcd6027f477
https://doi.org/10.1111/jop.12310
Zobrazit plný text záznamu
9
YAP1 is a potential biomarker for cetuximab resistance in head and neck cancer
Autor: Karin Roberg, Jenny Welander, Fredrik Jerhammar, Ann-Charlotte Johansson, Rebecca Ceder, Peter Söderkvist, Roland Grafström, Agneta Jansson
Publikováno v: Oral Oncology. 50:832-839
Targeted therapy against the epidermal growth factor receptor (EGFR) only variably represents a therapeutic advance in head and neck squamous cell carcinoma (HNSCC). This study addresses the need of biomarkers of treatment response to the EGFR-target
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eb66c1ae59ca9d04a45f0e860aeeb70
https://doi.org/10.1016/j.oraloncology.2014.06.003
Zobrazit plný text záznamu
10
EGFR status and EGFR ligand expression influence the treatment response of head and neck cancer cell lines
Autor: Adam Jedlinski, Ann-Charlotte Johansson, Anna Ansell, Karin Roberg
Publikováno v: Journal of Oral Pathology & Medicine. 42:26-36
Background: Combination treatment (chemoradiotherapy) is the standard treatment for locally advanced head and neck squamous cell carcinoma (HNSCC); however, treatment resistance and local recurrenc ...
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d3c8202b81652320ffadcfdac3907379
https://doi.org/10.1111/j.1600-0714.2012.01177.x
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje